CAAS Capital Management’s Pediatrix Medical MD Stock Holding History

CAAS Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-281,333	Closed	-$8M	–	973
2021 Q3	$8M	Buy	+281,333	New	+$8.57M	0.16%	135

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

CAAS Capital Management's MD Position: Q4 2021 in Review

CAAS Capital Management sold out of Pediatrix Medical (MD) in Q4 2021, closing a stake of 281,333 shares — an estimated $8M sold.

CAAS Capital Management first reported a position in MD in Q3 2021 and held it in 1 quarter. The position peaked at $8M in Q3 2021. 204 funds tracked by Wall St. Rank hold MD as of Q4 2021.

CAAS Capital Management reported no remaining Pediatrix Medical position as of Q4 2021 after selling out during the quarter.
CAAS Capital Management sold 281,333 Pediatrix Medical shares in Q4 2021, an estimated $8M.
CAAS Capital Management first reported a position in Pediatrix Medical in Q3 2021 and held it in 1 quarter.
CAAS Capital Management's Pediatrix Medical position peaked at $8M in Q3 2021.
204 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2021.

Based on CAAS Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.